for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Thyrocare Technologies Ltd

THYO.NS

Latest Trade

506.20INR

Change

4.65(+0.93%)

Volume

21,644

Today's Range

498.15

 - 

512.95

52 Week Range

407.15

 - 

604.70

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
501.55
Open
512.95
Volume
21,644
3M AVG Volume
0.50
Today's High
512.95
Today's Low
498.15
52 Week High
604.70
52 Week Low
407.15
Shares Out (MIL)
52.80
Market Cap (MIL)
26,726.47
Forward P/E
25.22
Dividend (Yield %)
3.95

Latest Developments

More

Thyrocare Technologies Wins Tender From Municipal Corporation Of Greater Mumbai

Thyrocare Technologies Ltd plans IPO in Feb-Business Standard

Thyrocare Technologies Ltd to consider IPO - ET

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its brands Nueclear and Whaters, respectively. The Company tests cover varied age groups from offerings for prenatal screening, to screening for hormonal imbalance, nutritional deficiencies and tracking lifestyle disorders.

Industry

Healthcare Facilities

Contact Info

D-37/1, Midc, Turbhe, Opp., Sandoz

+91.22.41252525

http://www.thyrocare.com/

Executive Leadership

Amruta Velumani

Executive Chairman of the Board, Chief Executive Officer, Managing Director

A. Sundararaju

Chief Financial Officer, Executive Director

Ramjee Dorai

Company Secretary and Head Secretarial and Legal

M. Chandrasekhar

General Manager - Infrastructure

Sachin Salvi

General Manager - Finance

Key Stats

1.83 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2017

3.1K

2018

3.6K

2019

4.0K

2020(E)

4.6K
EPS (INR)

2017

13.190

2018

17.750

2019

15.910

2020(E)

20.072
Price To Earnings (TTM)
30.23
Price To Sales (TTM)
6.43
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
22.84
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

BRIEF-Thyrocare Tech to discontinue existing arrangement with unit Nueclear Healthcare

* To discontinue existing arrangement with unit by which co was sourcing PET-CT business for them against fee of 20% of amount charged Source text: http://bit.ly/2kJMmDS Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up